Dr. Paula Scholz

Dr. Paula Scholz is the Head of Medical Affairs for Neurology, Immunology, and Ophthalmology in Germany at Bayer. She completed her medical studies and doctoral thesis at the University of Cologne, followed by ophthalmological training at the University Eye Center Cologne. As a Fellow of the European Board of Ophthalmology, Dr. Scholz possesses extensive expertise in her specialty. With extensive experience as an investigator in numerous clinical trials, she has actively contributed to various research projects, including studies focused on novel treatment approaches and patient outcomes. Dr. Scholz has published peer-reviewed articles in respected ophthalmology journals and serves as a referee for high-impact publications. In her role at Bayer, Dr. Scholz leverages her deep understanding of clinical and scientific aspects to bridge the gap between research and practical application. She has been instrumental in shaping medical strategies, providing insights for clinical development, and ensuring compliance with regulatory standards. Her experience in medical affairs has allowed her to foster collaborations with key opinion leaders and healthcare professionals, driving initiatives that enhance patient care.